Atlas Trials

Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects

Clinical trial NCT02594254 · COMPLETED

Trial details

NCT number
NCT02594254
Sponsor
Armata Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dental Caries
Start date
2015-11-01
Primary completion
2016-06-01
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.